• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人生长高度在 X 连锁低磷血症患者中数十年间得到改善:一项队列研究。

Adult height improved over decades in patients with X-linked hypophosphatemia: a cohort study.

机构信息

Pediatric Endocrinology Unit, Hôpital Universitaire de Bruxelles (HUB), Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université Libre de Bruxelles, Brussels 1020, Belgium.

AP-HP, Department of Endocrinology and Diabetes for Children, Department of Adolescent Medicine, Bicetre Paris-Saclay University Hospital, 78 Rue du General Leclerc, Le Kremlin-Bicêtre 94270, France.

出版信息

Eur J Endocrinol. 2023 Oct 17;189(4):469-475. doi: 10.1093/ejendo/lvad144.

DOI:10.1093/ejendo/lvad144
PMID:37831782
Abstract

OBJECTIVES

The aim of this study is to analyze height after cessation of growth (final height [FH]) and its evolution over the last decades in X-linked hypophosphatemia (XLH) patients in France, as the data on natural history of FH in XLH are lacking.

DESIGN

We performed a retrospective observational study in a large cohort of French XLH patients with available data on FH measurements.

MATERIALS AND METHODS

We divided patients into 3 groups according to their birth year: group 1 born between 1950 and 1974, group 2 born between 1975 and 2000, and group 3 born between 2001 and 2006, respectively, and compared their FHs.

RESULTS

A total of 398 patients were included. Mean FHs were the following: for group 1, -2.31 ± 1.11 standard deviation score (SDS) (n = 127), 156.3 ± 9.7 cm in men and 148.6 ± 6.5 cm in women; for group 2, -1.63 ± 1.13 SDS (n = 193), 161.6 ± 8.5 cm in men and 153.1 ± 7.2 cm in women; and for group 3, -1.34 ± 0.87 SDS (n = 78), 165.1 ± 5.5 cm in men and 154.7 ± 6 cm in women. We report a significant increase in mean FH SDS over 3 generations of patients, for both men and women (P < .001). Final height SDS in male (-2.08 ± 1.18) was lower than in female (-1.70 ± 1.12) (P = .002).

CONCLUSION

The FH of XLH patients in France increased significantly over the last decades. Even though men's FHs improved more than women's, men with XLH remain shorter reflecting a more severe disease phenotype. While the results are promising, most patients with XLH remain short leaving room for improvement.

摘要

目的

本研究旨在分析法国 X 连锁低磷血症(XLH)患者生长停止后的身高(最终身高[FH])及其在过去几十年中的变化,因为目前缺乏 XLH 患者 FH 的自然史数据。

设计

我们对一组有 FH 测量数据的法国 XLH 患者进行了回顾性观察性研究。

材料和方法

我们根据出生年份将患者分为 3 组:第 1 组出生于 1950 年至 1974 年,第 2 组出生于 1975 年至 2000 年,第 3 组出生于 2001 年至 2006 年,比较他们的 FH。

结果

共纳入 398 例患者。各组的平均 FH 如下:第 1 组,-2.31±1.11 标准差(SDS)(n=127),男性 161.6±8.5cm,女性 148.6±6.5cm;第 2 组,-1.63±1.13 SDS(n=193),男性 165.1±5.5cm,女性 154.7±6cm;第 3 组,-1.34±0.87 SDS(n=78),男性 165.1±5.5cm,女性 154.7±6cm。我们报告说,三代患者的平均 FH SDS 均显著增加,男性和女性均如此(P<.001)。男性(-2.08±1.18)的 FH SDS 低于女性(-1.70±1.12)(P=.002)。

结论

法国 XLH 患者的 FH 在过去几十年中显著增加。尽管男性的 FH 改善程度高于女性,但 XLH 男性仍较矮,反映出疾病表型更严重。尽管结果令人鼓舞,但大多数 XLH 患者仍身材矮小,仍有改善空间。

相似文献

1
Adult height improved over decades in patients with X-linked hypophosphatemia: a cohort study.成人生长高度在 X 连锁低磷血症患者中数十年间得到改善:一项队列研究。
Eur J Endocrinol. 2023 Oct 17;189(4):469-475. doi: 10.1093/ejendo/lvad144.
2
Phenotypic characterization of X-linked hypophosphatemia in pediatric Spanish population.X 连锁低磷血症在西班牙儿科人群中的表型特征。
Orphanet J Rare Dis. 2021 Feb 27;16(1):104. doi: 10.1186/s13023-021-01729-0.
3
X-Linked Hypophosphatemia: Uniquely Mild Disease Associated With PHEX 3'-UTR Mutation c.*231A>G (A Retrospective Case-Control Study).X连锁低磷血症:与PHEX 3'-UTR突变c.*231A>G相关的独特轻症疾病(一项回顾性病例对照研究)
J Bone Miner Res. 2020 May;35(5):920-931. doi: 10.1002/jbmr.3955. Epub 2020 Mar 10.
4
CRISPR/Cas9-mediated mutation of PHEX in rabbit recapitulates human X-linked hypophosphatemia (XLH).CRISPR/Cas9介导的兔PHEX基因突变模拟了人类X连锁低磷血症(XLH)。
Hum Mol Genet. 2016 Jul 1;25(13):2661-2671. doi: 10.1093/hmg/ddw125. Epub 2016 Apr 28.
5
Molecular Diagnoses of X-Linked and Other Genetic Hypophosphatemias: Results From a Sponsored Genetic Testing Program.X 连锁及其他遗传性低血磷症的分子诊断:一项赞助性基因检测计划的结果。
J Bone Miner Res. 2022 Feb;37(2):202-214. doi: 10.1002/jbmr.4454. Epub 2021 Nov 10.
6
Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion.X 连锁低磷血症性佝偻病导致身材矮小儿童的三年生长激素治疗:对线性生长和身体不成比例的影响。
J Clin Endocrinol Metab. 2011 Dec;96(12):E2097-105. doi: 10.1210/jc.2011-0399. Epub 2011 Oct 12.
7
Novel PHEX gene locus-specific database: Comprehensive characterization of vast number of variants associated with X-linked hypophosphatemia (XLH).新型 PHEX 基因座特异性数据库:对大量与 X 连锁低磷血症 (XLH) 相关的变异体进行全面特征描述。
Hum Mutat. 2022 Feb;43(2):143-157. doi: 10.1002/humu.24296. Epub 2021 Dec 5.
8
A Novel Synonymous Variant of PHEX in a Patient with X-Linked Hypophosphatemia.一个伴 X 连锁低磷血症患者的 PHEX 新型同义变异。
Calcif Tissue Int. 2022 Dec;111(6):634-640. doi: 10.1007/s00223-022-01003-w. Epub 2022 Jul 14.
9
Growth hormone treatment improves final height in children with X-linked hypophosphatemia.生长激素治疗可改善 X 连锁低磷血症患儿的最终身高。
Orphanet J Rare Dis. 2022 Dec 21;17(1):444. doi: 10.1186/s13023-022-02590-5.
10
Genotype-phenotype analysis, and assessment of the importance of the zinc-binding site in PHEX in Japanese patients with X-linked hypophosphatemic rickets using 3D structure modeling.利用 3D 结构建模对 X 连锁低磷血症性佝偻病日本患者 PHEX 中的锌结合位点进行基因型-表型分析及重要性评估。
Bone. 2021 Dec;153:116135. doi: 10.1016/j.bone.2021.116135. Epub 2021 Jul 30.

引用本文的文献

1
XLH Matters 2024: expert insights and practical tools for enhancing care of people living with X-linked hypophosphataemia.2024年XLH问题:改善X连锁低磷血症患者护理的专家见解与实用工具
Orphanet J Rare Dis. 2025 Sep 18;20(Suppl 2):477. doi: 10.1186/s13023-025-03930-x.
2
Experts' consensus on the management and treatment of individuals with X-linked hypophosphatemia across lifespan.关于X连锁低磷血症患者全生命周期管理与治疗的专家共识。
J Endocrinol Invest. 2025 Jul 1. doi: 10.1007/s40618-025-02611-7.
3
The Diagnosis and Therapy of XLH.
XLH的诊断与治疗。
Calcif Tissue Int. 2025 Apr 28;116(1):66. doi: 10.1007/s00223-025-01374-w.